CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 77 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $622 | -5.6% | 412 | 0.0% | 0.00% | – |
Q4 2022 | $659 | -78.0% | 412 | 0.0% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 412 | 0.0% | 0.00% | – |
Q4 2020 | $3,000 | 0.0% | 412 | -1.0% | 0.00% | – |
Q3 2020 | $3,000 | 0.0% | 416 | +1.0% | 0.00% | – |
Q1 2020 | $3,000 | +200.0% | 412 | +198.6% | 0.00% | – |
Q4 2019 | $1,000 | – | 138 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 1,877,148 | $13,853,000 | 1.46% |
Congress Park Capital LLC | 167,811 | $1,238,000 | 1.04% |
Perceptive Advisors | 3,253,923 | $24,014,000 | 0.65% |
RTW INVESTMENTS, LP | 990,463 | $7,310,000 | 0.44% |
Spark Investment Management LLC | 337,164 | $2,488,000 | 0.32% |
Exane Asset Management | 54,065 | $399,000,000 | 0.31% |
DAFNA Capital Management LLC | 100,000 | $738,000 | 0.28% |
HARBOURVEST PARTNERS LLC | 79,193 | $584,000 | 0.24% |
WELD CAPITAL MANAGEMENT LLC | 86,363 | $637,000 | 0.12% |
GSA CAPITAL PARTNERS LLP | 77,997 | $576,000 | 0.08% |